Bulletin
Investor Alert

Deciphera Pharmaceuticals Inc.

NAS: DCPH

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Aug 12, 2022, 6:36 p.m.

/zigman2/quotes/203556943/composite

$

16.38

Change

-0.03 -0.18%

Volume

Volume 23,900

Quotes are delayed by 20 min

/zigman2/quotes/203556943/composite

Previous close

$ 15.77

$ 16.41

Change

+0.64 +4.06%

Day low

Day high

$15.77

$16.43

Open

52 week low

52 week high

$6.51

$37.99

Open
Sorry, there are no transactions available for this individual.

Officers and Executives

Mr. Steven L. Hoerter
President & Chief Executive Officer
Mr. Thomas P. Kelly
Chief Financial Officer, Treasurer & Executive VP
Dr. Matthew L. Sherman
Chief Medical Officer & Executive Vice President
Dr. Rodrigo Ruiz Soto
Senior Vice President-Clinical Development
Dr. Daniel L. Flynn
Chief Scientific Officer & Executive VP
Dr. Stephen B. Ruddy
Chief Technical Officer & SVP
Ms. Kelley Dealhoy
Chief Business Officer & Senior Vice President
Mr. Daniel C. Martin
Chief Commercial Officer & SVP
Mr. Jeffrey M. Held
General Counsel & Senior Vice President
Mr. Jama Pitman
Vice President-Regulatory & Quality Assurance
Dr. James A. Bristol
Chairman
Dr. Susan L. Kelley
Independent Director
Mr. Ron Squarer
Independent Director
Mr. Franklin S. Friedman
Independent Director
Ms. Patricia L. Allen
Independent Director
Dr. Edward J. Benz
Independent Director
Mr. John R. Martin
Independent Director
Mr. Dennis L. Walsh
Independent Director
Link to MarketWatch's Slice.